",{"id":"SIGNIN"}).html('
×
').appendTo("body");jQuery("#SIGNIN").on('click',function(e){closeLogin()})},closeLogin=function(){jQuery("#SIGNIN").remove();jQuery("body").css("overflow","inherit")},adjustLoginHeight=function(h){jQuery("#Oframe").height(h)},login_success=function(sess){jQuery(".sign-up").html("LOGOUT").on('click',function(){location.href="https://signin."+DOMAIN+"/oauth/logout"});closeLogin()},LANG='en',commentHeight=function(data){jQuery("#block-ibt-comment iframe").height(data.height)};var login_success=function(sess){closeLogin();jQuery("article").removeClass("wall");jQuery(".login-btn .sign-up2").hide();jQuery(".login-btn .myaccount").show();jQuery(".only-before-login").hide();if(typeof sess=='object'){sess=sess.sess};jQuery("
",{"id":"TEMPE"}).html('').appendTo("body");jQuery("#TEMPE iframe").on("load",function(){jQuery("#TEMPE").remove();if(jQuery("iframe.comment").length){jQuery("iframe.comment").get(0).contentWindow.postMessage({'action':'success',},'*')}});afterLogin()};function afterLogin(){};doFir.push(function(){jQuery(document).ready(function(){jQuery(".sign-up2").on('click',function(e){e.preventDefault();e.stopPropagation();openLogin('https://signin.'+DOMAIN.replace(/ibtimes\.[\.a-z]+/,'ibtimes.com')+'/oauth?l='+jQuery(this).attr('data-lang'))})})})
Cometriq and Opdivo could likely receive approval next year as treatment for advanced kidney cancer after studies showed positive result. One study was halted earlier than schedule because patients taking Opdivo lived longer than those receiving standard treatment.